An Israeli company Kanabo Research wants to turn vaporizers from mostly recreational gadgets to medical devices. The company works on releasing its first medical vaporizer called VapePod. Kanabo is also developing a series of medical cannabis formulations for vaporizers.
Kanabo Research creates its vaporization formulations based on feedback from medical cannabis patients. The new products will be able to treat different disorders, including insomnia and anxiety.
In contrast to other pharmaceutical companies, Kanabo Research focuses on less known and popular cannabinoids present in the marijuana plant, like CBN (cannabinol). They try to increase the level of minor cannabinoids in their extracts, while still using all the benefits of THC and CBD.
Currently, the company works on seven different vaporization formulations. Five products are still under development and the two other formulations are patent-pending.
As for Kanabo's VapePod, the company tries to certify the vaporizer as a medical device. The main feature of this vaporizer is its ability to deliver precise and consistent doses of cannabis. The device activates when the user makes the first inhalation and keeps vibrating until the needed dosage of the extract is delivered.
The company wants to sell their products not only in Israel but also in Europe and in the US. Now, Kanabo hopes to get approval for both their cannabis extracts and medical vaporizer from the Israeli regulators. Then, the company will start working on getting approval from European regulators and FDA.